Oncology Insights: February 2025 - Prime Therapeutics
Oncology Insights: February 2025
Oncology Insights: Learnings and impact generated from artificial intelligence (AI) systems

Prime Therapeutics’ Oncology Insights focuses on trends, treatments, and spending in cancer care, highlighting key developments in oncology therapies. It offers analysis on the clinical value and cost implications of cancer medications to support informed decision-making for stakeholders.
About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.